Bio-Techne Corporation (NasdaqGS:TECH) will look for acquisitions. Charles R. Kummeth, Chief Executive Officer, President and Director said, "I think we're probably 1 or 2 small acquisitions away of filling out that workflow circle. As you know, we've got the Ella platform, we've got GMP proteins, we've got the Quad Cloudz beads. We don't have bioreactors. We have a partnership in place. We don't have gene editing, but we have a partnership in place. So there are some things we're still looking at to do that. And I would, I can't promise you acquisitions, but that is certainly where we're hunting. And given our history, it's probably likely we're going to get something."